Role of DNA methylation in colorectal carcinogenesis

Digestive Diseases

Volumn 30, Issue 3, 2012, Pages 310-315

  Patai, Árpád V ^a   Molnr, Béla ^a,b   Kalmár, Alexandra ^a   Schöller, Andrea ^a   Tóth, Kinga ^a   Tulassay, Zsolt ^a,b  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

Aging; Colorectal cancer; CpG island methylator phenotype; DNA methylation; Field effect; Prescreening; Ulcerative colitis

Indexed keywords

DNA METHYLTRANSFERASE; DNA METHYLTRANSFERASE INHIBITOR; HISTONE DEACETYLASE INHIBITOR;

AGING; ARTICLE; CARCINOGENESIS; COLON MUCOSA; COLONOSCOPY; COLORECTAL CANCER; CPG ISLAND; DNA METHYLATION; DNA MODIFICATION; DNA REPAIR; DRUG POTENTIATION; EPIGENETICS; GENE EXPRESSION; GENE MUTATION; GENE SEQUENCE; GENE SILENCING; HUMAN; PRIORITY JOURNAL; PROMOTER REGION; TUMOR SUPPRESSOR GENE; ULCERATIVE COLITIS;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; COLORECTAL NEOPLASMS; DNA METHYLATION; EARLY DETECTION OF CANCER; HUMANS; INFLAMMATION; PROMOTER REGIONS, GENETIC;

EID: 84862861689     PISSN: 02572753     EISSN: 14219875     Source Type: Journal    
DOI: 10.1159/000337004     Document Type: Article

References (39)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D: Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90.
2. Bestor TH: The DNA methyltransferases of mammals. Hum Mol Genet 2000; 9: 2395-2402.
3. Illingworth RS, Bird AP: CpG islands - 'a rough guide'. FEBS Lett 2009; 583: 1713-1720.
4. Taberlay PC, Jones PA: DNA methylation and cancer. Prog Drug Res 2011; 67: 1-23.
5. Irizarry RA, Ladd-Acosta C, Wen B, Wu Z, Montano C, Onyango P, Cui H, Gabo K, Rongione M, Webster M, Ji H, Potash JB, Sabunciyan S, Feinberg AP: The human colon cancer methylome shows similar hypoand hypermethylation at conserved tissuespecific CpG island shores. Nat Genet 2009; 41: 178-186.
6. De Smet C, Loriot A: DNA hypomethylation in cancer: epigenetic scars of a neoplastic journey. Epigenetics 2010; 5: 206-213.
7. Slaughter DP, Southwick HW, Sinejkal W: 'Field cancerization' in oral stratified squamous epithelium: Clinical implications of multicentric origin. Cancer (Phila) 1953; 6: 963-968.
8. Braakhuis BJM, Tabor MP, Kummer JA, Leemans CR, Brakenhoff RH: A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications. Cancer Res 2003; 63: 1727-1730. (Pubitemid 36460827)
9. Shen L, Kondo Y, Rosner GL, Xiao L, Hernandez NS, Vilaythong J, Houlihan PS, Krouse RS, Prasad AR, Einspahr JG, Buckmeier J, Alberts DS, Hamilton SR, Issa JP: MGMT promoter methylation and field defect in sporadic colorectal cancer. J Natl Cancer Inst 2005; 97: 1330-1338. (Pubitemid 41487800)
10. Esteller M, Toyota M, Sanchez-Cespedes M, Capella G, Peinado MA, Watkins DN, Issa JP, Sidransky D, Baylin SB, Herman JG: Inactivation of the DNA repair gene O6-methylguanine- DNA methyltransferase by promoter hypermethylation is associated with G to A mutations in K-ras in colorectal tumorigenesis. Cancer Res 2000; 60: 2368-2371. (Pubitemid 30262424)
11. Whitehall VL, Walsh MD, Young J, Leggett BA, Jass JR: Methylation of O-6-methylguanine DNA methyltransferase characterizes a subset of colorectal cancer with low-level DNA microsatellite instability. Cancer Res 2001; 61: 827-830. (Pubitemid 32174386)
12. Wilson VL, Jones PA: DNA methylation decreases in aging but not in immortal cells. Science 1983; 220: 1055-1057. (Pubitemid 13090144)
13. Issa JP, Ottaviano YL, Celano P, Hamilton SR, Davidson NE, Baylin SB: Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Nat Genet 1994; 7: 536-540. (Pubitemid 24308343)
14. Issa JPJ, Vertino PM, Boehm CD, Newsham IF, Baylin SB: Switch from monoallelic to biallelic human IGF2 promoter methylation during aging and carcinogenesis. Proc Natl Acad Sci USA 1996; 93: 11757-11762. (Pubitemid 26347196)
15. Ahuja N, Li Q, Mohan AL, Baylin SB, Issa JPJ: Aging and DNA methylation in colorectal mucosa and cancer. Cancer Res 1998; 58: 5489-5494. (Pubitemid 28551135)
16. Menigatti M, Truninger K, Gebbers JO, Marbet U, Marra G, Schär P: Normal colorectal mucosa exhibits sex- and segment-specific susceptibility to DNA methylation at the hMLH1 and MGMT promoters. Oncogene 2009; 28: 899-909.
17. Fujii S, Tominaga K, Kitajima K, Takeda J, Kusaka T, Fujita M, Ichikawa K, Tomita S, Ohkura Y, Ono Y, Imura J, Chiba T, Fujimori T: Methylation of the oestrogen receptor gene in non-neoplastic epithelium as a marker of colorectal neoplasia risk in longstanding and extensive ulcerative colitis. Gut 2005; 54: 1287-1292. (Pubitemid 41192492)
18. Hsieh CJ, Klump B, Holzmann K, Borchard F, Gregor M, Porschen R: Hypermethylation of the p16INK4a promoter in colectomy specimens of patients with long-standing and extensive ulcerative colitis. Cancer Res 1998; 58: 3942-3945. (Pubitemid 28405652)
19. Issa JP, Ahuja N, Toyota M, Bronner MP, Brentnall TA: Accelerated age-related CpG island methylation in ulcerative colitis. Cancer Res 2001; 61: 3573-3577. (Pubitemid 32694963)
20. Garrity-Park MM, Loftus EV Jr, Sandborn WJ, Bryant SC, Smyrk TC: Methylation status of genes in non-neoplastic mucosa from patients with ulcerative colitis-Associated colorectal cancer. Am J Gastroenterol 2010; 105: 1610-1619.
21. Saito S, Kato J, Hiraoka S, Horii J, Suzuki H, Higashi R, Kaji E, Kondo Y, Yamamoto K: DNA methylation of colon mucosa in ulcerative colitis patients: Correlation with inflammatory status. Inflamm Bowel Dis 2011; 17: 1955-1965.
22. Niwa T, Ushijima T: Induction of epigenetic alterations by chronic inflammation and its significance on carcinogenesis. Adv Genet 2010; 71: 41-56.
23. Brenner H, Chang-Claude J, Seiler CM, Rickert A, Hoffmeister M: Protection from colorectal cancer after colonoscopy: A population- based, case-control study. Ann Intern Med 2011; 154: 22-30.
24. Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, Nakamura Y, White R, Smits AM, Bos JL: Genetic alterations during colorectal-Tumor development. N Engl J Med 1988; 319: 525-532.
25. Arain MA, Sawhney M, Sheikh S, et al: CIMP status of interval colon cancers: Another piece to the puzzle. Am J Gastroenterol 2010; 105: 1189-1195.
26. Leggett B, Whitehall V: Role of the serrated pathway in colorectal cancer pathogenesis. Gastroenterology 2010; 138: 2088-2100.
27. Toyota M, Ahuja N, Ohe-Toyota M, Herman JG, Baylin SB, Issa JP: CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci USA 1999; 96: 8681-8686. (Pubitemid 29354851)
28. Park SJ, Rashid A, Lee JH, Kim SG, Hamilton SR, Wu TT: Frequent CpG island methylation in serrated adenomas of the colorectum. Am J Pathol 2003; 162: 815-822. (Pubitemid 36237490)
29. Weisenberger DJ, Siegmund KD, Campan M, Young J, Long TI, Faasse MA, Kang GH, Widschwendter M, Weener D, Buchanan D, Koh H, Simms L, Barker M, Leggett B, Levine J, Kim M, French AJ, Thibodeau SN, Jass J, Haile R, Laird PW: CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat Genet 2006; 38: 787-793. (Pubitemid 43980599)
30. Nosho K, Shima K, Irahara N, Kure S, Baba Y, Kirkner GJ, Chen L, Gokhale S, Hazra A, Spiegelman D, Giovannucci EL, Jaenisch R, Fuchs CS, Ogino S: DNMT3B expression might contribute to CpG island methylator phenotype in colorectal cancer. Clin Cancer Res 2009; 15: 3663-3671.
31. Ibrahim AE, Arends MJ, Silva AL, Wyllie AH, Greger L, Ito Y, Vowler SL, Huang TH, Tavaré S, Murrell A, Brenton JD: Sequential DNA methylation changes are associated with DNMT3B overexpression in colorectal neoplastic progression. Gut 2011; 60: 499-508.
32. Samowitz WS, Albertsen H, Sweeney C, Herrick J, Caan BJ, Anderson KE, Wolff RK, Slattery ML: Association of smoking, CpG island methylator phenotype, and V600E BRAF mutations in colon cancer. J Natl Cancer Inst 2006; 98: 1731-1738. (Pubitemid 44942711)
33. Hughes LA, van den Brandt PA, de Bruïne AP, Wouters KA, Hulsmans S, Spiertz A, Goldbohm RA, de Goeij AF, Herman JG, Weijenberg MP, van Engeland M: Early life exposure to famine and colorectal cancer risk: A role for epigenetic mechanisms. PLoS One 2009; 4:e7951.
34. Grützmann R, Molnar B, Pilarsky C, Habermann JK, Schlag PM, Saeger HD, Miehlke S, Stolz T, Model F, Roblick UJ, Bruch HP, Koch R, Liebenberg V, Devos T, Song X, Day RH, Sledziewski AZ, Lofton-Day C: Sensitive detection of colorectal cancer in peripheral blood by septin 9 DNA methylation assay. PLoS One 2008; 3:e3759.
35. Tänzer M, Balluff B, Distler J, Hale K, Leodolter A, Röcken C, Molnar B, Schmid R, Lofton- Day C, Schuster T, Ebert MP: Performance of epigenetic markers SEPT9 and ALX4 in plasma for detection of colorectal precancerous lesions. PLoS One 2010; 5:e9061.
36. Lee BB, Lee EJ, Jung EH, Chun HK, Chang DK, Song SY, Park J, Kim DH: The present study suggests that tumor-specific methylation of APC, MGMT, RASSF2A, and Wif-1 genes might be a valuable biomarker in plasma for the early detection of colorectal cancer. Clin Cancer Res 2009; 15: 6185-6191.
37. Azuara D, Rodriguez-Moranta F, de Oca J, Soriano-Izquierdo A, Mora J, Guardiola J, Biondo S, Blanco I, Peinado MA, Moreno V, Esteller M, Capellá G: Novel methylation panel for the early detection of colorectal tumors in stool DNA. Clin Colorectal Cancer 2010; 9: 168-176.
38. Ren J, Singh BN, Huang Q, Li Z, Gao Y, Mishra P, Hwa YL, Li J, Dowdy SC, Jiang SW: DNA hypermethylation as a chemotherapy target. Cell Signal 2011; 23: 1082-1093.
39. Ogino S, Chan AT, Fuchs CS, Giovannucci E: Molecular pathological epidemiology of colorectal neoplasia: An emerging transdisciplinary and interdisciplinary field. Gut 2011; 60: 397-411.